Healthcare

Nova Mentis (OTC: NMLSF) to Produce Psilocybin Capsules for Phase 2A Clinical Study

Manufacturing Contract with the Toronto Institute of Pharmaceutical Technology VANCOUVER, BC, April 7, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics […]

No Picture
Newsmakers

AITX’s (OTC: AITX) Subsidiary Robotic Assistance Devices Receives Multiple ROSA Order from a Leading Energy Company

Detroit, Michigan, April 07, 2022 — Artificial Intelligence Technology Solutions, Inc., (OTC: AITX), today announced that its wholly owned subsidiary Robotic Assistance Devices, Inc. (RAD) has received an order for 4 ROSA security robots from one […]

No Picture
Newsmakers

Tonix Pharmaceuticals (NASDAQ: TNXP) Initiates Enrollment in the RESILIENT Study, a Potentially Pivotal Phase 3 Study of TNX-102 SL for the Management of Fibromyalgia

Results from Planned Interim Analysis Expected First Quarter 2023 A Positive Outcome in RESILIENT Together with Results from Previous Positive Phase 3 Study RELIEF May Support Submission of an NDA CHATHAM, N.J., April 07, 2022 […]

Newsmakers

Nextech AR (OTC: NEXCF) Expands 3D Patent Portfolio Files Four Pivotal Non-Provisional Utility Patents

TORONTO, April 06, 2022—-Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a Metaverse Company and leading provider of augmented reality (“AR”) experience technologies and services is pleased […]

Newsmakers

ORAGIN’s (OTC: OGGFF) Future of Cheese Receives U.S. Food and Drug Administration (FDA) Registration, Allowing for North American Wide Direct Sales

ORAGIN makes stock option grant to a director of the Company with significant industry experience who will take an active role in the development and growth of the Company and its subsidiary Future of Cheese […]

Newsmakers

DeepMarkit (OTC: MKTDF) Attending the North American Carbon World Conference from April 6-8th in Anaheim

The Company also Endorses the SEC’s Ground-Breaking Proposal to Implement a Rule that Would Require all Public Companies to Report Their Carbon Emissions CALGARY, AB, April 6, 2022  – DeepMarkit Corp., (“DeepMarkit” or the “Company”) (TSXV: MKT) […]

CEO Interview

NEXT SUPER STOCK NexTech AR (OTC: NEXCF) (CSE: NTAR) “On-Ramp to Metaverse & Web 3.0 for $5 Trillion E-Commerce Market”

NEXT SUPER STOCK NexTech AR (OTC: NEXCF) (CSE: NTAR) is the On-Ramp to Metaverse & Web 3.0 for $5 Trillion E-Commerce Market. 4/5/22 livestream ABOUT THE EVENT NEXT SUPER STOCK Live! is Wall Street Reporter’s […]

No Picture
Newsmakers

Sunshine Biopharma’s (NASDAQ: SBFM) Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells

A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments MONTREAL, April 05, 2022 — Sunshine Biopharma, Inc. (NASDAQ: SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, […]

No Picture
Newsmakers

CLINIGENCE HOLDINGS AND NUTEX HEALTH (NASDAQ: NUTX) ANNOUNCE COMPLETION OF MERGER AND LISTING ON THE NASDAQ CAPITAL MARKET

FORT LAUDERDALE, Fla. and HOUSTON, April 4, 2022 /PRNewswire/ — Clinigence Holdings, Inc. (“Clinigence” or the “Company”) (OTC: NUTX), a primary care-centric, technology-enabled, risk-bearing population health management company, and Nutex Health Holdco LLC (“Nutex Holdco”), together with its affiliates […]

Newsmakers

DeepMarkit (OTC: MKTDF) Appoints Oscar Mendoza and Geoffrey Fielding to Advisory Board

The Formation of the Special Advisory Board Strengthens and Guides the Company’s Mission to Democratize Access To Global Carbon Credit Markets CALGARY, AB, March 29, 2022  – DeepMarkit Corp., (“DeepMarkit” or the “Company”) (TSXV: MKT) (OTC: MKTDF) (FRA: DEP), a […]

Healthcare

Pharmadrug (OTC: LMLLF)Advances PD-001, Its Patented, Improved Version of Cepharanthine for Oncology and Infectious Disease

Committed to the ‘pipeline-in-a-pill’ approach with PD-001 for certain cancers and COVID-19 Advances cGMP manufacturing of clinical drug supply with Southwest Research Institute Receives final positive data for recently conducted prostate cancer model and evaluates […]